The Foundation for Women’s Cancer Announces 2013 Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher

The Foundation for Women’s Cancer and the Claudia Cohen Research Foundation announce today that Dr. Robert C. Bast, Jr. has been selected as the 2013 recipient of the Foundation for Women’s Cancer/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 prize is being presented at the Society of Gynecologic Oncologists 44th Annual Meeting on Women's Cancer in Los Angeles.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
"I am deeply grateful for this recognition of our group’s work and pledge that we will never give up until we have eliminated the threat of ovarian cancer to women worldwide."
~Dr. Robert C. Bast, Jr.

Los Angeles, CA (PRWEB) March 09, 2013

The Foundation for Women’s Cancer and the Claudia Cohen Research Foundation announce today that Dr. Robert C. Bast, Jr. has been selected as the 2013 recipient of the Foundation for Women’s Cancer/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 prize is being presented at the Society of Gynecologic Oncologists 44th Annual Meeting on Women's Cancer in Los Angeles.

Dr. Bast is Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, where he holds the Harry Carothers Wiess Distinguished University Chair for Cancer Research. His major research interests include understanding the biology of ovarian and breast cancers, eliminating dormant ovarian cancer cells, enhancing the activity of conventional chemotherapy and detecting ovarian cancer at an earlier stage when it can be treated more effectively. His early work with murine monoclonal antibodies led to the development of the CA 125 test, widely used today to monitor women with ovarian cancer with potential to be used as a screening test in the future. Dr. Bast also has been a devoted mentor to many of the today’s leaders in gynecologic oncology.

Each year more than 88,000 women will be diagnosed with a gynecologic cancer and about 29,000 will die from these cancers. Gynecologic cancers include cervical, ovarian, uterine, vaginal and vulvar cancers.

”Over the last three decades real progress has been made in managing ovarian cancer, but much more needs to be done at an even faster pace. I am deeply grateful for this recognition of our group’s work and pledge that we will never give up until we have eliminated the threat of ovarian cancer to women worldwide,” said Dr. Bast.    

The prize is funded by the Claudia Cohen Research Foundation in honor of Claudia Cohen, who lost her battle with uterine leiomyosarcoma in 2007. Ms. Cohen was a highly respected journalist and philanthropist. The Claudia Cohen Research Foundation was founded by Ms. Cohen's daughter Samantha and her sisters Caleigh and Debra Perelman, to foster research aimed at reducing the burden of gynecologic cancer.

“We are proud that the Claudia Cohen Research Foundation can celebrate the work of talented researchers who are endeavoring to conquer gynecologic cancer,” said Dr. Eric A. Rose, advisory board member, Claudia Cohen Research Foundation.

The Claudia Cohen Prize for Outstanding Gynecologic Researcher is one of two prizes, one stipend and eight ovarian cancer grants announced during the SGO Annual Meeting. See the attached document for the full list of this year's research award winners.

Since announcing its first grant in 1995, the Foundation for Women’s Cancer has awarded 104 research grants, totaling more than $5 million. Its research program targets promising young investigators who often receive their initial funding from the Foundation. The Foundation is grateful to the many families and individuals who give generously each year to support this important research endeavor.

“Our partnership with the Claudia Cohen Research Foundation allows us to recognize our most productive researchers and provide key support as they continue to explore critical questions about how to improve outcomes for women diagnosed with a gynecologic cancer,” said Dr. David M. Gershenson, Chairman, Foundation for Women’s Cancer.

For more information about the Foundation for Women’s Cancer and the prevention, early detection and optimal treatment of gynecologic cancers, visit foundationforwomenscancer.org. For more information about the Claudia Cohen Research Foundation, visit claudicohenfoundation.org.

About the Foundation for Women’s Cancer
The Foundation for Women’s Cancer is dedicated to expanding public awareness, education, research and training to improve the prevention, early detection and optimal treatment of gynecologic cancers. A national organization dedicated to the eradication of all reproductive cancers, the Foundation has provided more than $5 million in research funding since 1995, earning recognition from Worth Magazine as one of the nation's 100 best charities.

About the Claudia Cohen Research Foundation
The Claudia Cohen Research Foundation, established in 2009, is dedicated exclusively to support research leading to the treatment, control, and prevention of gynecologic cancer with a special emphasis on gynecologic sarcoma. The mission of The Claudia Cohen Prize for Outstanding Gynecologic Cancer Research is to champion the achievement of leaders in cutting-edge research by awarding an annual $50,000 prize.